The herbicide sulfometuron methyl is a potent inhibitor of the branched-chain amino acid biosynthetic enzyme acetolactate synthase (ALS) isolated from bacteria, fungi, and plants. However, it did not prevent growth of wild-type Salmonella typhimurium LT2 or Escherichia coli K-12. These species each contain two acetolactate synthase isozymes. Growth of S. typhimurium and E. coli mutants lacking ALS I was prevented by the herbicide, suggesting that activity of the remaining ALS isoenzyme (II or III, respectively) was stopped by sulfometuron methyl. Synthesis of ALS I requires either an reLA function or an elevated cyclic AMP level. A reL4 mutant of S. typhimurium was inhibited by sulfometuron methyl on rich carbon sources that display a basal cyclic AMP level but not on poor carbon sources where the cyclic AMP concentration is elevated. When Lvaline, which allosterically inhibits ALS I activity, was added, growth retardation of the reL4-strain by sulfometuron methyl was observed on both poor and rich carbon sources. Enzymological analyses indicated that ALS I activities derived from both species were resistant to the herbicide. In contrast, activities of S. typhimurium ALS II and E. coli ALS III were abolished by sulfometuron methyl.
The herbicide sulfometuron methyl (SM) (N-[(4,6-dimethylpyrimidin -2 -yl)aminocarbonyl] -2-methoxycarbonylbenzene sulfonamide) is also an inhibitor of bacterial (13) and fungal growth (S. C. Falco and K. Dumas, manuscript in preparation). It disrupts branched-chain amino acid biosynthesis in organisms as diverse as peas (17) , yeasts (Falco and Dumas, in preparation), and Salmonella typhimurium (13) . Biochemical genetic analyses of Saccharomyces cerevisiae (Falco and Dumas, in preparation), Nicotina tabacum (4), and S. typhimurium (13) have demonstratesd that an acetolactate synthase (ALS; EC 4.1.3.18) activity of each organism is the target of the herbicide. ALS catalyzes two biosynthetic reactions: (i) 2 pyruvate -> o-acetolactate + CO2 and (ii) pyruvate + ot-ketobutyrate -> ot-aceto-ox-hydroxybutyrate + CO2. These are parallel reactions in valine and isoleucine biosynthesis (22) with thiamine pyrophosphate as a cofactor (12) .
In the enteric bacteria S. typhimurium and Escherichia coli, ALS activity is specified by isozymes I, II, and III encoded by the genes ilvB, ilvG, and ilvHI, respectively (8) . The ilvG gene product, ALS II, is not produced by E. coli K-12; the ilvHI gene is cryptic in S. typhimurium (8) . It has been suggested that the ALS I activity of S. typhimurium is unaffected by SM (13) . This report demonstrates that the ALS I of both E. coli and S. typhimurium was insensitive to SM. Thus enterobacterial ALS I was unique; it was the only wild-type acetolactate-forming enzyme described whose catalytic activity was resistant to obstruction by SM. were plated on Bochner selection medium, which permits propagation of tetracycline-sensitive cells while retarding growth of tetracycline-resistant bacteria (3) . Imprecise excision mutants of strain TT7542 unlike true revertants, retain a RelA-phenotype. That relA mutants are more sensitive than isogenic relA+ strains to many antagonists of amino acid biosynthesis (19) provides the basis for their identification. Imprecise excision derivatives were thus recognized by screening for progeny displaying the RelA-phenotypes of sensitivity to the histidine antimetabolite aminotriazole (20 (8) . Valine inclusion caused wild-type S. typhimurium to be inhibited by SM on glucose minimal mediunm. This inhibition could be reversed by isoleucine (13; data not shown). An interpietation (13) is that SM inhibits S. typhimurium ALS II but not ALS I; if this interpretation is correct, growth inhibition is only manifested when ALS I activity is blocked or absent. Consistent with this interpretation was the response to SM of strain RL511, which harbors an insertion of Tn5 in the ilvB structural gene. Although lacking ALS I activity, the strain was prototrophic due to ALS II activity; however, it was unable to grow in the presence of SM ( Table  2 ), suggesting that valine potentiates wild-type growth retardation via feedback inhibition of ALS I.
Strains carrying relA mutations are often hypersensitive to amino acid antagonists (19) . Three different relA mutants were inhibited by SM on glucose minimal mnedium (Table 3) . This finding is consistent with the known dependence of ALS I expression upon relA function (10) . SM inhibition of these relA mutant strains was slightly reversed by L-valine. This result contrasts with the wild-type response of L-valine potentiation of herbicide inhibition. This contrast reinforces the suggestion (10, 21) that only ALS II is present at a significant concentration in relA-cells grown on minimal glucose medium, cAMP and carbon source effects. The relA requirement for transcription of the ALS I structural gene ilvB can be replaced by cyclic AMP (cAMP) (10, 11, 21) . In solidified M9 medium with glucose as a carbon source, the zone diameter of SM-mediated growth inhibition of the relA-strain TV7542.3 was decreased from 38 mmn without cAMP to 28 mm with 2mM cAMP. Similar though less complete reversal was observed with sorbitol as the carbon source; cAMP inclusion caused a decrease in zonle diameter from 39 to 34 mm. Growth on poor carbon sources, known to cause elevated cAMP levels (1, 15) completely abolished SM inhibition of the relA-strain TV7542.3 (Table 4) . Inclusion of valine in the medium prevented the reversal of SM inhibition of this strain by poor carbon sources (Table 4) . Since valine inhibits ALS I activity, this result was again consistent with the hypothesis that ALS I is responsible for cell growth in the presence of SM.
S. typhimurium ALS I activity was resistant to inhibition by SM in vitro. In S. typhimurium there are two physiologically significant ALS (I and II) activities (8) . An extract (prepared from strain TT66) containing ALS I, but no other ALS isozyme, was assayed for acetolactate-forming capacity. ALS I activity was uninhibited by SM at concentrations ranging from 1 to 100 ,uM. Conversely, ALS II activity has previously been shown to be significantly inhibited by SM; biphasic inhibition with an initial Ki of 660 nM and a final Ki of 65 nM has been reported (13). E. coli isozymes. A different pair of ALS isozymes (I and III) exists in E. coli K-12 (9). Wild-type E. coli K-12 was resistant to SM ( Table 5 ). The E. coli strains M1253 and CU200 (ilvH ilvl), containing only ALS I, were as resistant to SM growth retardation as was the wild type (Table 5 ). In contrast, an ilvB mutant (CU847) that harbors only ALS III was sensitive to SM. This indicates that, of the three enterobacterial isozymes, only ALS I is resistant to SM. Acetolactate formation catalyzed by various E. coli extracts in the presence and absence of SM was measured. Activity of strain MC4100, containing both ALS I and III, was partially inhibited by inclusion of 1 mM SM in the assay mix (data not shown). ALS I activity extracted from the ilvH ilvI strain M1253 was quite insensitive to 1 mM SM (Fig. 1A) . Similar results were obtained with the ilvH ilvI deletion strain CU200 (data not shown). In contrast, ALS III activity present in strain CU847 was completely inhibited by this SM concentration (Fig. iB) . DISCUSSION Inhibition of ALS by SM is a widespread phenomenon occurring with extracts obtained from plant, fungal, and bacterial sources. Only a single wild-type ALS is known to be completely resistant to SM. This distinctive enzyme is ALS I of the enteric bacteria S. typhimurium and E. coli. The insensitivity of ALS I to SM is advantageous in many ways. It provides a first means for measuring ALS I activity in crude extracts containing ALS II, ALS III, or both. Thus, activity of this isozyme can be conveniently monitored in any strain. Since ALS I is insensitive to SM, ilvB is potentially useful as a dominant selectable marker for the genetic transformation of diverse organisms.
The basis for differential sensitivity of ALS isozymes to SM is unknown. The three isozymes catalyze identical I, III  <6  M1253  I  <6  CU200  I  <6  CU847  III  13c, 17t " All strains were plated on thiamine and glucose containing Vogel-Bonner minimal E medium. Auxotrophies required that this medium be supplemented with threonine, leucine, or proline for the growth of M1253, CU200, or CU847, respectively. For symbols, see footnote b of Table 2. reactions, albeit at differing efficiencies and under distinct allosteric controls (8) . Perhaps the preference of S. typhimurium and E. ccli ALS I for pyruvate as the recipient of the cofactor-bound hydroxyethyl moiety (9, 16, 18 ) is significant. Evidence suggests that the recipient pocket within the catalytic site of ALS I cannot efficiently accommodate the larger substrate, a-ketobutyrate (9) . Furthermore, we suggest that the ability to efficiently accommodate ax-ketobutyrate is required for SM interaction with the active sites. All known SM-sensitive ALS proteins (4, 13, 17 (14) . ALS I synthesis (10, 21) , like that of many surface proteins (1, 15) , is controlled by the cya and crp genes. Such control of amino acid biosynthetic genes is most unusual (21, (22) . In the aromatic and aspartate family pathways, each isozyme is controlled by a separate end product (22) . This is not true of the ALS isozymes (8) . Thus, the ability to selectively interfere with a single enzymic species may be useful in studies of the catabolic- (8) and metabolic-interlock (7) functions attributed to the ALS isozymes.
